Treatment through a clinical trial may be an option for some people with leukemia. Several factors may influence your decision to join a clinical trial, so it’s important to gather as much information ...
Please provide your email address to receive an email when new articles are posted on . myeloMATCH will quickly evaluate genomic profiles of adults with leukemia and enroll them in a matched clinical ...
SENTI-202, an off-the-shelf CAR NK cell therapy for AML, received FDA orphan drug designation, supporting its development for relapsed or refractory cases. LYL314, a CAR T-cell therapy for large ...
Please provide your email address to receive an email when new articles are posted on . In this video, Douglas Tremblay, MD, discusses the results of a study into a first-line treatment of chronic ...
A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong ...
At 37, Melvin Mann began experiencing persistent back pain and fatigue. After undergoing several tests in 1994, doctors diagnosed the Army major with a form of blood cancer called chronic myeloid ...
Acute myeloid leukemia is one of the deadliest cancers. Leukemic stem cells responsible for the disease are highly resistant to treatment. A team has made a breakthrough by identifying some of the ...
90% of frontline AML patients achieved remission with mipletamig plus ven/aza, surpassing the 66% rate seen with ven/aza alone. No cytokine release syndrome (CRS) has been reported in the RAINIER ...
Moleculin Biotech Inc. MBRX said it remains on track to unblind the first set of data from its pivotal Phase 2B/3 MIRACLE ...
Scientists at McGill University have found a way to supercharge the immune system’s natural killer (NK) cells, helping them break through the defenses tumors use to stay alive. By temporarily blocking ...
Chronic lymphocytic leukemia (CLL) remains an incurable disease, except in rare cases treated with allogeneic stem-cell transplantation or favorable-risk CLL treated with chemoimmunotherapy. Treatment ...
18don MSN
Leukemia stem cells cause treatments to fail, but findings open new avenues to overcome resistance
Scientists from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute have deciphered a key mechanism that contributes to treatment failure in acute myeloid leukemia (AML). They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results